Planned sale of 5,466 common shares filed

Rhea-AI Filing Summary

GLUE filed a Rule 144 notice for a planned stock sale. The filing covers a proposed sale of 5,466 shares of common stock through Rockefeller Capital Management, with an aggregate market value of $128,372.00. The shares are expected to be sold on or about January 7, 2026 on the NASDAQ, and the issuer had 65,117,761 shares outstanding.

The securities to be sold are tied to a stock award of 21,865 RSUs acquired on January 2, 2025 from the issuer as compensation, with a stated payment date of January 2, 2026. The person on whose behalf the sale is planned represents that they do not know of any material adverse, nonpublic information about the issuer’s current or prospective operations, and the form allows for reliance on a Rule 10b5-1 trading plan if such a plan date is indicated.

FAQ

What does the GLUE Rule 144 filing disclose about planned share sales?

The notice discloses a planned sale of 5,466 shares of GLUE common stock through Rockefeller Capital Management, with an aggregate market value of $128,372.00, expected around January 7, 2026 on the NASDAQ.

How many GLUE shares are outstanding in this Rule 144 notice?

The filing states that the issuer of GLUE common stock had 65,117,761 shares outstanding at the time referenced in the notice.

What is the origin of the GLUE shares to be sold under Rule 144?

The securities to be sold are linked to a RSU stock award of 21,865 units acquired on January 2, 2025 from the issuer as compensation, with a payment date of January 2, 2026.

Which broker is handling the planned GLUE share sale?

The Rule 144 notice lists Rockefeller Capital Management, 500 Boylston Street, Suite 1300, Boston, MA 02116 as the broker for the planned sale of GLUE common shares.

What representation does the seller make in the GLUE Rule 144 notice?

By signing the notice, the person for whose account the GLUE securities are to be sold represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.

Does the GLUE Rule 144 filing reference Rule 10b5-1 trading plans?

Yes. The notice provides a field for the Date of Plan Adoption or Giving of Instruction if the person relies on a Rule 10b5-1 trading plan or instructions, and states that the above representation applies as of that adoption or instruction date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/07/2026 - 04:58 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001855643
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Monte Rosa Therapeutics, Inc.
SEC File Number	001-40522
Address of Issuer	321 HARRISON AVENUE SUITE 900 BOSTON MASSACHUSETTS 02118
Phone	617-949-2643
Name of Person for Whose Account the Securities are To Be Sold	Warmuth Markus
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Rockefeller Capital Management 500 Boylston Street Suite 1300 Boston MA 02116	5466	128372.00	65117761	01/07/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
RSU	01/02/2025	Stock Award	From Issuer			21865	01/02/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	01/07/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	05/14/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Carmen Zamores as a duly authorized representative of National Financial Services LLC, as attorney-in-fact for Warmuth Markus
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)